Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin

OBJECTIVE: Rosiglitazone was found associated with approximately a 43% increase in risk of acute myocardial infarction (AMI) in a two meta-analyses of clinical trials. Our objective is to estimate the magnitude of the association in real-world patients previously treated with metformin. RESEARCH DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormuth, Colin R., Maclure, Malcolm, Carney, Greg, Schneeweiss, Sebastian, Bassett, Ken, Wright, James M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698985/
https://www.ncbi.nlm.nih.gov/pubmed/19562036
http://dx.doi.org/10.1371/journal.pone.0006080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698985/
https://www.ncbi.nlm.nih.gov/pubmed/19562036
http://dx.doi.org/10.1371/journal.pone.0006080

Ejemplares similares